Share Price and Basic Stock Data
Last Updated: January 22, 2026, 2:49 pm
| PEG Ratio | -13.96 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Uravi Defence & Technology Ltd operates within the Auto Ancillary Equipment Lamp sector, with a market capitalization of ₹216 Cr and a current share price of ₹189. For the financial year ending March 2025, the company reported total sales of ₹43.63 Cr, with a trailing twelve-month (TTM) sales figure of ₹43.51 Cr. The quarterly sales figures indicate fluctuations, with the highest sales recorded in September 2025 at ₹12.07 Cr, while the lowest was in December 2024 at ₹10.02 Cr. This variability may reflect seasonal demand dynamics or operational challenges within the sector. The operating profit margin (OPM) for September 2025 stood at 5.14%, significantly lower than the peak OPM of 15.35% recorded in March 2025. This decline in profitability underscores potential cost pressures that the company may be facing, which could impact long-term sustainability if not addressed effectively.
Profitability and Efficiency Metrics
In terms of profitability, Uravi Defence reported a net profit of ₹2.55 Cr for the fiscal year ending March 2025, with a TTM net profit of ₹2.12 Cr. The earnings per share (EPS) for March 2025 was ₹2.18, while the diluted EPS stood at ₹2.25. However, the company’s profitability metrics have shown a concerning trend, especially with a net loss of ₹0.05 Cr reported in September 2025. The interest coverage ratio (ICR) was recorded at 3.54 times, indicating that the company can comfortably meet its interest obligations. The cash conversion cycle (CCC) was notably high at 511.92 days, highlighting inefficiencies in managing working capital. This prolonged cycle could strain liquidity, making it essential for Uravi Defence to enhance operational efficiency to improve overall profitability.
Balance Sheet Strength and Financial Ratios
Uravi Defence’s balance sheet reflects a mix of strengths and challenges. As of March 2025, the company’s total borrowings stood at ₹25.88 Cr, with total assets amounting to ₹88.77 Cr. The debt-to-equity ratio of 0.55 indicates a moderate level of leverage, which is manageable but requires monitoring. The company reported reserves of ₹35.10 Cr, which increased to ₹38.98 Cr by September 2025, suggesting a positive trend in retained earnings. However, the price-to-book value ratio (P/BV) of 8.52x indicates that the stock may be overvalued compared to its net assets, which could deter potential investors. The current ratio of 1.90 demonstrates adequate short-term liquidity, but the quick ratio of 1.11 reveals that the company may face challenges converting its assets into cash quickly, particularly in a tight financial environment.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Uravi Defence has seen significant changes over recent quarters. As of September 2025, promoters held 58.39% of the company, down from 72.73% in December 2022, signaling a potential dilution of control. Foreign institutional investors (FIIs) have increased their stake to 8.24%, indicating growing confidence among international investors. The public shareholding has risen to 33.38%, reflecting an increase in retail interest. The number of shareholders also climbed dramatically to 3,133 by September 2025, up from just 236 in December 2022. This increase in shareholder base can enhance liquidity but may also lead to volatility if retail investors react to market sentiment. Overall, while the growing public interest is a positive sign, the declining promoter stake may raise concerns regarding long-term strategic direction and governance.
Outlook, Risks, and Final Insight
Looking ahead, Uravi Defence faces a mixed outlook. The company’s ability to stabilize and enhance profitability will be critical, particularly in light of the declining OPM and the recent net loss. Operational inefficiencies, as indicated by the high cash conversion cycle, pose a significant risk that could affect liquidity and growth. However, the increasing public and foreign investment interest could provide the necessary capital for operational improvements. The company’s moderate leverage and growing reserves offer some financial stability, but the high P/BV ratio suggests cautious valuation. Uravi Defence must focus on optimizing its operations and addressing cost pressures to regain market confidence. The path forward will hinge on effective management strategies that can navigate both internal challenges and external market conditions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Varroc Engineering Ltd | 8,557 Cr. | 560 | 695/365 | 44.2 | 110 | 0.18 % | 17.1 % | 7.37 % | 1.00 |
| Uravi Defence & Technology Ltd | 226 Cr. | 198 | 588/153 | 110 | 44.2 | 0.00 % | % | % | 10.0 |
| Lumax Industries Ltd | 4,643 Cr. | 4,964 | 5,878/1,960 | 31.1 | 873 | 0.70 % | 16.4 % | 19.3 % | 10.0 |
| Fiem Industries Ltd | 5,774 Cr. | 2,192 | 2,445/1,156 | 25.8 | 410 | 1.37 % | 27.8 % | 21.0 % | 10.0 |
| Industry Average | 4,800.00 Cr | 1,978.50 | 52.78 | 359.30 | 0.56% | 20.43% | 15.89% | 7.75 |
Quarterly Result
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Sales | 11.12 | 10.02 | 11.40 | 10.02 | 12.07 |
| Expenses | 9.62 | 9.08 | 9.65 | 8.80 | 11.45 |
| Operating Profit | 1.50 | 0.94 | 1.75 | 1.22 | 0.62 |
| OPM % | 13.49% | 9.38% | 15.35% | 12.18% | 5.14% |
| Other Income | 0.07 | 0.37 | 0.33 | 0.40 | 0.27 |
| Interest | 0.57 | 0.40 | 0.39 | 0.39 | 0.38 |
| Depreciation | 0.55 | 0.55 | 0.51 | 0.52 | 0.48 |
| Profit before tax | 0.45 | 0.36 | 1.18 | 0.71 | 0.03 |
| Tax % | 33.33% | 25.00% | 31.36% | 25.35% | 233.33% |
| Net Profit | 0.35 | 0.71 | 0.93 | 0.53 | -0.05 |
| EPS in Rs | 0.32 | 0.65 | 0.75 | 0.38 | 0.07 |
Last Updated: December 28, 2025, 4:33 pm
Below is a detailed analysis of the quarterly data for Uravi Defence & Technology Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 12.07 Cr.. The value appears strong and on an upward trend. It has increased from 10.02 Cr. (Jun 2025) to 12.07 Cr., marking an increase of 2.05 Cr..
- For Expenses, as of Sep 2025, the value is 11.45 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.80 Cr. (Jun 2025) to 11.45 Cr., marking an increase of 2.65 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.62 Cr.. The value appears to be declining and may need further review. It has decreased from 1.22 Cr. (Jun 2025) to 0.62 Cr., marking a decrease of 0.60 Cr..
- For OPM %, as of Sep 2025, the value is 5.14%. The value appears to be declining and may need further review. It has decreased from 12.18% (Jun 2025) to 5.14%, marking a decrease of 7.04%.
- For Other Income, as of Sep 2025, the value is 0.27 Cr.. The value appears to be declining and may need further review. It has decreased from 0.40 Cr. (Jun 2025) to 0.27 Cr., marking a decrease of 0.13 Cr..
- For Interest, as of Sep 2025, the value is 0.38 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.39 Cr. (Jun 2025) to 0.38 Cr., marking a decrease of 0.01 Cr..
- For Depreciation, as of Sep 2025, the value is 0.48 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.52 Cr. (Jun 2025) to 0.48 Cr., marking a decrease of 0.04 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 0.71 Cr. (Jun 2025) to 0.03 Cr., marking a decrease of 0.68 Cr..
- For Tax %, as of Sep 2025, the value is 233.33%. The value appears to be increasing, which may not be favorable. It has increased from 25.35% (Jun 2025) to 233.33%, marking an increase of 207.98%.
- For Net Profit, as of Sep 2025, the value is -0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.53 Cr. (Jun 2025) to -0.05 Cr., marking a decrease of 0.58 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.07. The value appears to be declining and may need further review. It has decreased from 0.38 (Jun 2025) to 0.07, marking a decrease of 0.31.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:27 am
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 43.63 | 43.51 |
| Expenses | 37.85 | 38.98 |
| Operating Profit | 5.78 | 4.53 |
| OPM % | 13.25% | 10.41% |
| Other Income | 0.97 | 1.37 |
| Interest | 1.91 | 1.56 |
| Depreciation | 2.05 | 2.06 |
| Profit before tax | 2.79 | 2.28 |
| Tax % | 30.11% | |
| Net Profit | 2.55 | 2.12 |
| EPS in Rs | 2.18 | 1.85 |
| Dividend Payout % | 0.00% |
YoY Net Profit Growth
| Year |
|---|
| YoY Net Profit Growth (%) |
| Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 49% |
| 3 Years: | 44% |
| 1 Year: | -25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 4, 2025, 2:10 am
| Month | Mar 2025 | Sep 2025 |
|---|---|---|
| Equity Capital | 11.26 | 11.36 |
| Reserves | 35.10 | 38.98 |
| Borrowings | 25.88 | 25.71 |
| Other Liabilities | 16.53 | 14.08 |
| Total Liabilities | 88.77 | 90.13 |
| Fixed Assets | 19.58 | 19.26 |
| CWIP | 2.71 | 2.78 |
| Investments | 0.19 | 8.98 |
| Other Assets | 66.29 | 59.11 |
| Total Assets | 88.77 | 90.13 |
Below is a detailed analysis of the balance sheet data for Uravi Defence & Technology Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 11.36 Cr.. The value appears strong and on an upward trend. It has increased from 11.26 Cr. (Mar 2025) to 11.36 Cr., marking an increase of 0.10 Cr..
- For Reserves, as of Sep 2025, the value is 38.98 Cr.. The value appears strong and on an upward trend. It has increased from 35.10 Cr. (Mar 2025) to 38.98 Cr., marking an increase of 3.88 Cr..
- For Borrowings, as of Sep 2025, the value is 25.71 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 25.88 Cr. (Mar 2025) to 25.71 Cr., marking a decrease of 0.17 Cr..
- For Other Liabilities, as of Sep 2025, the value is 14.08 Cr.. The value appears to be improving (decreasing). It has decreased from 16.53 Cr. (Mar 2025) to 14.08 Cr., marking a decrease of 2.45 Cr..
- For Total Liabilities, as of Sep 2025, the value is 90.13 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 88.77 Cr. (Mar 2025) to 90.13 Cr., marking an increase of 1.36 Cr..
- For Fixed Assets, as of Sep 2025, the value is 19.26 Cr.. The value appears to be declining and may need further review. It has decreased from 19.58 Cr. (Mar 2025) to 19.26 Cr., marking a decrease of 0.32 Cr..
- For CWIP, as of Sep 2025, the value is 2.78 Cr.. The value appears strong and on an upward trend. It has increased from 2.71 Cr. (Mar 2025) to 2.78 Cr., marking an increase of 0.07 Cr..
- For Investments, as of Sep 2025, the value is 8.98 Cr.. The value appears strong and on an upward trend. It has increased from 0.19 Cr. (Mar 2025) to 8.98 Cr., marking an increase of 8.79 Cr..
- For Other Assets, as of Sep 2025, the value is 59.11 Cr.. The value appears to be declining and may need further review. It has decreased from 66.29 Cr. (Mar 2025) to 59.11 Cr., marking a decrease of 7.18 Cr..
- For Total Assets, as of Sep 2025, the value is 90.13 Cr.. The value appears strong and on an upward trend. It has increased from 88.77 Cr. (Mar 2025) to 90.13 Cr., marking an increase of 1.36 Cr..
Notably, the Reserves (38.98 Cr.) exceed the Borrowings (25.71 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2025 |
|---|---|
Free Cash Flow
| Month | Mar 2025 |
|---|---|
| Free Cash Flow | -20.10 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2025 |
|---|---|
| Debtor Days | 119.97 |
| Inventory Days | 453.33 |
| Days Payable | 61.37 |
| Cash Conversion Cycle | 511.92 |
| Working Capital Days | 122.81 |
| ROCE % |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 |
|---|---|
| FaceValue | 10.00 |
| Basic EPS (Rs.) | 2.31 |
| Diluted EPS (Rs.) | 2.25 |
| Cash EPS (Rs.) | 3.55 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 41.18 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 41.18 |
| Revenue From Operations / Share (Rs.) | 38.75 |
| PBDIT / Share (Rs.) | 5.99 |
| PBIT / Share (Rs.) | 4.17 |
| PBT / Share (Rs.) | 2.48 |
| Net Profit / Share (Rs.) | 1.73 |
| NP After MI And SOA / Share (Rs.) | 2.18 |
| PBDIT Margin (%) | 15.46 |
| PBIT Margin (%) | 10.76 |
| PBT Margin (%) | 6.39 |
| Net Profit Margin (%) | 4.46 |
| NP After MI And SOA Margin (%) | 5.63 |
| Return on Networth / Equity (%) | 5.30 |
| Return on Capital Employeed (%) | 8.54 |
| Return On Assets (%) | 2.76 |
| Long Term Debt / Equity (X) | 0.02 |
| Total Debt / Equity (X) | 0.55 |
| Current Ratio (X) | 1.90 |
| Quick Ratio (X) | 1.11 |
| Interest Coverage Ratio (X) | 3.54 |
| Interest Coverage Ratio (Post Tax) (X) | 2.02 |
| Enterprise Value (Cr.) | 411.15 |
| EV / Net Operating Revenue (X) | 9.42 |
| EV / EBITDA (X) | 60.94 |
| MarketCap / Net Operating Revenue (X) | 9.05 |
| Price / BV (X) | 8.52 |
| Price / Net Operating Revenue (X) | 9.05 |
| EarningsYield | 0.01 |
After reviewing the key financial ratios for Uravi Defence & Technology Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.25. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.55. This value is within the healthy range. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.18. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.18. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 38.75. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.99. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 25, the value is 4.17. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.48. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.73. This value is below the healthy minimum of 2. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.18. This value is within the healthy range. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 25, the value is 15.46. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 25, the value is 10.76. This value is within the healthy range. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 25, the value is 6.39. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 25, the value is 4.46. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.63. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.30. This value is below the healthy minimum of 15. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.54. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 25, the value is 2.76. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.55. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 25, the value is 1.90. This value is within the healthy range. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 25, the value is 1.11. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.54. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.02. This value is below the healthy minimum of 3. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 25, the value is 411.15. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.42. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 25, the value is 60.94. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.05. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 25, the value is 8.52. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.05. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Uravi Defence & Technology Ltd:
- Net Profit Margin: 4.46%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.54% (Industry Average ROCE: 20.43%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.3% (Industry Average ROE: 15.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.02
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.11
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 110 (Industry average Stock P/E: 52.78)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.55
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.46%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Auto Ancl - Equipment Lamp | Shop No. 329 Avior, Nirmal Galaxy, Mumbai Maharashtra 400080 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Niraj Damji Gada | Managing Director & CEO |
| Mr. Kaushik Damji Gada | WholeTime Director & CFO |
| Mr. Shlok Kaushik Gada | Whole Time Director |
| Ms. Shreya Ramkrishnan | Ind. Non-Executive Director |
| Mr. Sreedhar Ramachandran Ayalur | Ind. Non-Executive Director |
| Mr. Niken Shah | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Uravi Defence & Technology Ltd?
Uravi Defence & Technology Ltd's intrinsic value (as of 22 January 2026) is ₹548.22 which is 176.88% higher the current market price of ₹198.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹226 Cr. market cap, FY2025-2026 high/low of ₹588/153, reserves of ₹38.98 Cr, and liabilities of ₹90.13 Cr.
What is the Market Cap of Uravi Defence & Technology Ltd?
The Market Cap of Uravi Defence & Technology Ltd is 226 Cr..
What is the current Stock Price of Uravi Defence & Technology Ltd as on 22 January 2026?
The current stock price of Uravi Defence & Technology Ltd as on 22 January 2026 is ₹198.
What is the High / Low of Uravi Defence & Technology Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Uravi Defence & Technology Ltd stocks is ₹588/153.
What is the Stock P/E of Uravi Defence & Technology Ltd?
The Stock P/E of Uravi Defence & Technology Ltd is 110.
What is the Book Value of Uravi Defence & Technology Ltd?
The Book Value of Uravi Defence & Technology Ltd is 44.2.
What is the Dividend Yield of Uravi Defence & Technology Ltd?
The Dividend Yield of Uravi Defence & Technology Ltd is 0.00 %.
What is the ROCE of Uravi Defence & Technology Ltd?
The ROCE of Uravi Defence & Technology Ltd is %.
What is the ROE of Uravi Defence & Technology Ltd?
The ROE of Uravi Defence & Technology Ltd is %.
What is the Face Value of Uravi Defence & Technology Ltd?
The Face Value of Uravi Defence & Technology Ltd is 10.0.